Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback